Özlem Türeci
Founder en BIONTECH SE .
Fortuna: 84 M $ al 31/03/2024
Perfil
zlem Treci fundó BioNTech SE y Ganymed Pharmaceuticals AG. En la actualidad, es presidenta de Ci3 Management UG, presidenta de la Asociación para la Inmunoterapia del Cáncer y directora médica de BioNTech SE. En el pasado ocupó el cargo de Directora Ejecutiva y Médica de Ganymed Pharmaceuticals AG. La Dra. Treci se licenció en la Universitt des Saarlandes.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BIONTECH SE
0.38% | 31/12/2023 | 913 247 ( 0.38% ) | 84 M $ | 31/03/2024 |
Cargos activos de Özlem Türeci
Empresas | Cargo | Inicio |
---|---|---|
BIONTECH SE | Founder | 02/06/2008 |
Association For Cancer Immunotherapy | President | - |
Ci3 Management UG | Chairman | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Özlem Türeci.
Empresas | Cargo | Fin |
---|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Executive Officer | - |
Formación de Özlem Türeci.
Universität des Saarlandes | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIONTECH SE | Health Technology |
Empresas privadas | 4 |
---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
Association For Cancer Immunotherapy | |
Ci3 Management UG |
- Bolsa de valores
- Insiders
- Özlem Türeci